Vertex Pharmaceuticals Inc (VRTX)
471.12
-4.86
(-1.02%)
USD |
NASDAQ |
Nov 01, 16:00
471.00
-0.12
(-0.03%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap: 121.60B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 121.60B |
| October 31, 2024 | 122.85B |
| October 30, 2024 | 122.62B |
| October 29, 2024 | 121.40B |
| October 28, 2024 | 122.95B |
| October 25, 2024 | 123.30B |
| October 24, 2024 | 121.80B |
| October 23, 2024 | 121.32B |
| October 22, 2024 | 122.58B |
| October 21, 2024 | 123.40B |
| October 18, 2024 | 124.66B |
| October 17, 2024 | 128.72B |
| October 16, 2024 | 125.76B |
| October 15, 2024 | 125.00B |
| October 14, 2024 | 125.13B |
| October 11, 2024 | 124.33B |
| October 10, 2024 | 122.90B |
| October 09, 2024 | 120.78B |
| October 08, 2024 | 118.45B |
| October 07, 2024 | 115.78B |
| October 04, 2024 | 117.52B |
| October 03, 2024 | 117.06B |
| October 02, 2024 | 119.28B |
| October 01, 2024 | 121.25B |
| September 30, 2024 | 120.04B |
| Date | Value |
|---|---|
| September 27, 2024 | 119.47B |
| September 26, 2024 | 119.54B |
| September 25, 2024 | 119.18B |
| September 24, 2024 | 119.50B |
| September 23, 2024 | 118.73B |
| September 20, 2024 | 120.00B |
| September 19, 2024 | 123.35B |
| September 18, 2024 | 122.38B |
| September 17, 2024 | 124.21B |
| September 16, 2024 | 126.32B |
| September 13, 2024 | 125.28B |
| September 12, 2024 | 123.54B |
| September 11, 2024 | 122.53B |
| September 10, 2024 | 121.51B |
| September 09, 2024 | 121.59B |
| September 06, 2024 | 120.79B |
| September 05, 2024 | 120.94B |
| September 04, 2024 | 123.52B |
| September 03, 2024 | 122.78B |
| August 30, 2024 | 127.99B |
| August 29, 2024 | 127.33B |
| August 28, 2024 | 126.40B |
| August 27, 2024 | 123.97B |
| August 26, 2024 | 124.57B |
| August 23, 2024 | 124.21B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
45.35B
Minimum
Oct 05 2021
130.54B
Maximum
Aug 01 2024
76.40B
Average
72.18B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 777.42B |
| Bristol-Myers Squibb Co | 110.17B |
| Regeneron Pharmaceuticals Inc | 92.70B |
| Sarepta Therapeutics Inc | 11.76B |
| Moderna Inc | 21.00B |
Market Cap Related Metrics
| PS Ratio | 11.86 |
| Price to Book Value | 8.230 |
| Price | 471.12 |
| Earnings Yield | -0.43% |
| Operating PE Ratio | 29.19 |
| Normalized PE Ratio | 39.54 |